Department of Trauma and Orthopedic Surgery, Plastic, Hand and Reconstructive Surgery, Armed Forces Hospital Westerstede, Westerstede, Germany.
Department of Plastic, Aesthetic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.
Mil Med Res. 2020 Apr 26;7(1):21. doi: 10.1186/s40779-020-00250-y.
Limb loss has a drastic impact on a patient's life. Severe trauma to the extremities is common in current military conflicts. Among other aspects, "life before limb" damage control surgery hinders immediate replantation within the short post-traumatic timeframe, which is limited in part by the ischemic time for successful replantation. Ex vivo limb perfusion is currently being researched in animal models and shows promising results for its application in human limb replantation and allotransplantation.
The current lack of replantation possibilities in military operations with high rates of amputation can be addressed with the development of a portable ex vivo limb perfusion device, as there are several opportunities present with the introduction of this technique on the horizon. We hypothesize that ex vivo limb perfusion will enable overcoming the critical ischemic time, provide surgical opportunities such as preparation of the stump and limb, allow for spare-part surgery, enable rigorous antibiotic treatment of the limb, reduce ischemia-reperfusion injuries, enable a tissue function assessment before replantation, and enable the development of large limb transplant programs.
Data from in vivo studies in porcine models are limited by the relatively short perfusion time of 24 h. In the military setting, notably longer perfusion times need to be realized. Therefore, future animal studies must focus especially on long-term perfusion, since this represents the military setting, considering the time for stabilization of the patient until evacuation to a tertiary treatment center.
The development and clinical introduction of ex vivo limb perfusion in the military setting could lead to a drastic reduction in the number of limb amputations among service members. Ex vivo limb perfusion enables replantation surgery in Role 4 facilities and changes the clinical setting from a highly urgent, life-threatening situation to a highly methodical, well-prepared starting point for optimal treatment of the wounded service member. With its introduction, the principle of "life before limb" will change to "life before limb before elective replantation/allotransplantation after ex vivo limb perfusion".
肢体丧失对患者的生活有巨大影响。目前的军事冲突中,四肢严重创伤很常见。除此之外,“肢体存活前”损伤控制手术会妨碍在短暂的创伤后时间内立即进行再植,这在一定程度上受到成功再植的缺血时间限制。目前正在动物模型中研究离体肢体灌注,并且其在人类肢体再植和同种异体移植中的应用具有广阔前景。
目前在高截肢率的军事行动中,再植的可能性有限,可以通过开发便携式离体肢体灌注设备来解决,因为随着这项技术的引入,有几个机会摆在面前。我们假设离体肢体灌注将能够克服临界缺血时间,提供手术机会,如残端和肢体准备,进行备用组织手术,实现对肢体的严格抗生素治疗,减少缺血再灌注损伤,在再植前评估组织功能,并能够开展大型肢体移植项目。
猪模型的体内研究数据受到 24 小时相对较短的灌注时间的限制。在军事环境中,需要实现更长的灌注时间。因此,未来的动物研究必须特别关注长期灌注,因为这代表了军事环境,考虑到患者稳定到转移到三级治疗中心的时间。
在军事环境中开发和临床引入离体肢体灌注可能会导致军人肢体截肢数量大幅减少。离体肢体灌注使 4 级设施能够进行再植手术,并将临床环境从高度紧急、危及生命的情况转变为高度有条理、充分准备的起点,为伤员提供最佳治疗。随着其引入,“肢体存活前”的原则将变为“离体肢体灌注前的肢体存活前,然后进行离体肢体灌注后的选择性再植/同种异体移植”。